PT - JOURNAL ARTICLE AU - Philip S. Robinson AU - Laura E. Thomas AU - Federico Abascal AU - Hyunchul Jung AU - Luke M.R. Harvey AU - Hannah D. West AU - Sigurgeir Olafsson AU - Bernard C. H. Lee AU - Tim H.H. Coorens AU - Henry Lee-Six AU - Laura Butlin AU - Nicola Lander AU - Mathijs A. Sanders AU - Stefanie V. Lensing AU - Simon J.A. Buczacki AU - Rogier ten Hoopen AU - Nicholas Coleman AU - Roxanne Brunton-Sim AU - Simon Rushbrook AU - Kourosh Saeb-Parsy AU - Fiona Lalloo AU - Peter J. Campbell AU - IƱigo Martincorena AU - Julian R. Sampson AU - Michael R. Stratton TI - Inherited <em>MUTYH</em> mutations cause elevated somatic mutation rates and distinctive mutational signatures in normal human cells AID - 10.1101/2021.10.20.465093 DP - 2021 Jan 01 TA - bioRxiv PG - 2021.10.20.465093 4099 - http://biorxiv.org/content/early/2021/10/22/2021.10.20.465093.short 4100 - http://biorxiv.org/content/early/2021/10/22/2021.10.20.465093.full AB - Cellular DNA damage caused by reactive oxygen species is repaired by the base excision repair (BER) pathway which includes the DNA glycosylase MUTYH. Inherited biallelic MUTYH mutations cause predisposition to colorectal adenomas and carcinoma. However, the mechanistic progression from germline MUTYH mutations to MUTYH-Associated Polyposis (MAP) is incompletely understood. Here, we sequenced normal tissue DNAs from 10 individuals with MAP. Somatic base substitution mutation rates in intestinal epithelial cells were elevated 2 to 5-fold in all individuals, except for one showing a 33-fold increase, and were also increased in other tissues. The increased mutation burdens were of multiple mutational signatures characterised by C&gt;A changes. Different mutation rates and signatures between individuals were likely due to different MUTYH mutations or additional inherited mutations in other BER pathway genes. The elevated base substitution rate in normal cells likely accounts for the predisposition to neoplasia in MAP. Despite ubiquitously elevated mutation rates, individuals with MAP do not display overt evidence of premature ageing. Thus, accumulation of somatic mutations may not be sufficient to cause the global organismal functional decline of ageing.SummaryCompeting Interest StatementP.J.C. is a founder, consultant, and stockholder of Mu Genomics Ltd.